Literature DB >> 4578298

Cellular requirements for the rejection of skin allografts in rats.

D M Lubaroff.   

Abstract

The role of bone marrow-derived cells in the rejection of skin allografts in rats was investigated. Lewis rats, rendered tolerant of BN antigens and bearing healthy grafts, were thymectomized, irradiated with 900 rad, and injected with varying doses of either normal isologous bone marrow, normal lymph node cells, and/or lymph node cells presensitized to BN antigens. In some experiments rats were also adoptively sensitized to tuberculin. Results showed that, although necessary for the elicitation of tuberculin skin reactions, bone marrow cells are not needed for the rejection of previously tolerated skin allografts. Rats receiving lymph node cells alone rejected their grafts in about 6-7 days. In addition, rats injected with bone marrow alone also rejected their grafts, although significantly later than did lymph node cell recipients, indicating that rat marrow contains a population of cells capable of reacting to transplantation antigens. These cells were found capable of reacting to major transplantation antigens but not minor as they were ineffective in causing the rejection of Ag-B compatible Fischer skin grafts. From experiments utilizing bone marrow from neonatally thymectomized donors and cells treated with an antiserum to rat T cells, these competent cells in the marrow were shown to be thymus derived.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4578298      PMCID: PMC2139399          DOI: 10.1084/jem.138.2.331

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  21 in total

1.  The passive transfer of delayed hypersensitivity in guinea pigs by the transfusion of isotopically-labelled lymphoid cells.

Authors:  J L TURK
Journal:  Immunology       Date:  1962-07       Impact factor: 7.397

2.  The pattern of rejection in rat skin homografts, and its relation to the vascular network.

Authors:  B H WAKSMAN
Journal:  Lab Invest       Date:  1963-01       Impact factor: 5.662

3.  Prolongation of survival of skin homotransplants in the rabbit by irradiation of the host.

Authors:  W J DEMPSTER; B LENNOX; J W BOAG
Journal:  Br J Exp Pathol       Date:  1950-10

4.  Studies on the isolation of lymphocytes active in cell-mediated immune responses. I. Demonstration of an active population of thymus-derived cells in mouse bone marrow.

Authors:  R Burleson; R H Levey
Journal:  Cell Immunol       Date:  1972-08       Impact factor: 4.868

5.  Radioautographic study of cellular mechanisms in delayed hypersensitivity. IV. Distribution of injected lymph node, spleen, thymus and bone marrow cells.

Authors:  T U Kosunen
Journal:  Immunology       Date:  1970-07       Impact factor: 7.397

6.  Bone marrow and lymph node cells in the rejection of skin allografts in mice.

Authors:  J P Giroud; W G Spector; D A Willoughby
Journal:  Immunology       Date:  1970-12       Impact factor: 7.397

7.  Composition, morphology, and source of cells in delayed skin reactions.

Authors:  C Bosman; J D Feldman
Journal:  Am J Pathol       Date:  1970-02       Impact factor: 4.307

8.  Tuberculin hypersensitivity: studies with radioactive antigen and mononuclear cells.

Authors:  K KAY; W O RIEKE
Journal:  Science       Date:  1963-02-08       Impact factor: 47.728

9.  Role of the thymus in tolerance. I. Tolerance to bovine gamma globulin in thymectomized, irradiated rats grafted with thymus from tolerant donors.

Authors:  K Isaković; S B Smith; B H Waksman
Journal:  J Exp Med       Date:  1965-12-01       Impact factor: 14.307

10.  SPECIFICITY OF PASSIVELY TRANSFERRED DELAYED HYPERSENSITIVITY.

Authors:  J S NAJARIAN; J D FELDMAN
Journal:  J Exp Med       Date:  1963-09-01       Impact factor: 14.307

View more
  1 in total

1.  Immunomagnetic T-lymphocyte depletion (ITLD) of rat bone marrow using OX-19 monoclonal antibody.

Authors:  A L Hoffman; L Makowka; D V Cramer; X Cai; A Pascualone; B F Banner; D G Sheahan; P Rettinger; T E Starzl
Journal:  J Invest Surg       Date:  1989       Impact factor: 2.533

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.